Cargando…

Exploring the prognostic function of TMB-related prognostic signature in patients with colon cancer

Tumor mutation burden (TMB) level is identified as a useful predictor in multiple tumors including colon adenocarcinoma (COAD). However, the function of TMB related genes has not been explored previously. In this study, we obtained patients’ expression and clinical data from The Cancer Genome Atlas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yan, Liang, Xiaolong, Duan, Xudong, Zhang, Chengli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214595/ https://www.ncbi.nlm.nih.gov/pubmed/37237274 http://dx.doi.org/10.1186/s12920-023-01555-2

Ejemplares similares

Exploring Immune-Related Prognostic Signatures in the Tumor Microenvironment of Colon Cancer
por: Cao, Lichao, et al.
Publicado: (2022)

The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer
por: Wei, Jiayan, et al.
Publicado: (2021)

The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients
por: Cui, Shengjin, et al.
Publicado: (2023)

Construction of an immune-related signature with prognostic value for colon cancer
por: Lv, Yunxia, et al.
Publicado: (2021)

Identification of cuproptosis related subtypes and construction of prognostic signature in gastric cancer
por: Dong, Hao, et al.
Publicado: (2023)

Construction and Verification of a Fibroblast-Related Prognostic Signature Model for Colon Cancer
por: Zhao, Zhe, et al.
Publicado: (2022)

Prognostic value of tumor mutation burden (TMB) and INDEL burden (IDB) in cancer: current view and clinical applications
por: Saeed, Anwaar, et al.
Publicado: (2020)

Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project
por: Merino, Diana M, et al.
Publicado: (2020)

The prognostic value of TMB in early-stage non-small cell lung cancer: a systematic review and meta-analysis
por: Wankhede, Durgesh, et al.
Publicado: (2023)

Genomic and transcriptomic profiling indicates the prognosis significance of mutational signature for TMB-high subtype in Chinese patients with gastric cancer
por: Cheng, Yanan, et al.
Publicado: (2022)

Prognostic costimulatory molecule-related signature risk model correlates with immunotherapy response in colon cancer
por: Huang, Wanze, et al.
Publicado: (2023)

Gene pair based prognostic signature for colorectal colon cancer
por: Shu, Peng, et al.
Publicado: (2018)

Construction and Validation of a Cell Cycle-Related Robust Prognostic Signature in Colon Cancer
por: Zhang, Zhiyuan, et al.
Publicado: (2020)

A Ferroptosis-Related Gene Signature Identified as a Novel Prognostic Biomarker for Colon Cancer
por: Qi, Xin, et al.
Publicado: (2021)

Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients
por: Yan, Dan, et al.
Publicado: (2021)

Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer
por: Sun, Xianchao, et al.
Publicado: (2021)

TMB in NSCLC: A Broken Dream?
por: Bravaccini, Sara, et al.
Publicado: (2021)

Identification and Verification of a 17 Immune-Related Gene Pair Prognostic Signature for Colon Cancer
por: Zhang, Qianshi, et al.
Publicado: (2021)

Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer
por: Wu, Zhiwei, et al.
Publicado: (2022)

Epithelial–Mesenchymal Transition Gene Signature Related to Prognostic in Colon Adenocarcinoma
por: Busuioc, Constantin, et al.
Publicado: (2021)

Development of an exosome-related and immune microenvironment prognostic signature in colon adenocarcinoma
por: Cui, Guoliang, et al.
Publicado: (2022)

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)

An exploration of LAF‐bTMB as a predictor for the efficacy of immunotherapy combined with chemotherapy in non—small cell lung cancer
por: Zhang, Shuyang, et al.
Publicado: (2022)

Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer
por: Zhang, Xiangyu, et al.
Publicado: (2022)

Identifying Inconsistencies and Reporting Deficits in Therapeutic Massage and Bodywork (TMB) Case Reports Authored by TMB Practitioners: a TMB-Adapted CAse REport (CARE) Guidelines Audit Through 2014
por: Munk, Niki, et al.
Publicado: (2016)

An autophagy-related prognostic signature associated with immune microenvironment features of uveal melanoma
por: Zheng, Zhuotao, et al.
Publicado: (2021)

Deciphering the Pyroptosis-Related Prognostic Signature and Immune Cell Infiltration Characteristics of Colon Cancer
por: Wei, Ran, et al.
Publicado: (2021)

Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma
por: Zhang, Jingyao, et al.
Publicado: (2023)

Tissue-Plasma TMB Comparison and Plasma TMB Monitoring in Patients With Metastatic Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors
por: Friedlaender, Alex, et al.
Publicado: (2020)

The role of a cuproptosis-related prognostic signature in colon cancer tumor microenvironment and immune responses
por: Xu, Chenyang, et al.
Publicado: (2022)

Baseline lesion number as an efficacy predictive and independent prognostic factor and its joint utility with TMB for PD-1 inhibitor treatment in advanced gastric cancer
por: Wei, Xiao-Li, et al.
Publicado: (2021)

Open the Technical Black Box of Tumor Mutational Burden (TMB): Factors Affecting Harmonization and Standardization of Panel-Based TMB
por: Sung, Meng-Ta, et al.
Publicado: (2022)

Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma
por: Miao, Yan-Dong, et al.
Publicado: (2021)

Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma
por: Zheng, Lian, et al.
Publicado: (2021)

Screening Gene Expression-Related Alternative Splicing Event Signature for Colon Cancer Prognostic Prediction
por: Xu, Jie, et al.
Publicado: (2022)

Prognostic value and immune infiltration of novel signatures in colon cancer microenvironment
por: Lin, Yilin, et al.
Publicado: (2021)

Exploration of novel clusters and prognostic value of immune‑related signatures and identify HAMP as hub gene in colorectal cancer
por: Wu, Hongyuan, et al.
Publicado: (2023)

Immune cell infiltration-associated signature in colon cancer and its prognostic implications
por: Deng, Dan, et al.
Publicado: (2021)

Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer
por: Liu, Yunze, et al.
Publicado: (2022)

Exploration of the Immune-Related Long Noncoding RNA Prognostic Signature and Inflammatory Microenvironment for Cervical Cancer
por: Yao, Hui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rdkldbkak24gecrg2lh25monb0